Since we have already known that TAZ is required for and sufficient to maintain self-renewal and tumor initiation capability of breast cancer stem cells (Cordenonsi et al., 2011), it’s interesting to study whether TAZ-induced temozolomide resistance is related to TAZ’s function in GSCs. This evidence concerns the gene WWTR1 and neoplasm.